(GEV) GE Vernova - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US36828A1016
Stock: Gas Turbines, Wind Turbines, Grid Solutions, Power Conversion, Energy Storage
Total Rating 78
Risk 71
Buy Signal 1.33
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.23% |
| Yield on Cost 5y | 0.96% |
| Yield CAGR 5y | 200.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 7.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 52.9% |
| Relative Tail Risk | -7.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.57 |
| Alpha | 89.40 |
| Character TTM | |
|---|---|
| Beta | 1.630 |
| Beta Downside | 1.662 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.29% |
| CAGR/Max DD | 4.23 |
Description: GEV GE Vernova January 26, 2026
GE Vernova LLC (NYSE:GEV) is a newly-incorporated energy firm headquartered in Cambridge, MA that delivers end-to-end electricity solutions across five continents. It operates through three distinct segments: Power (gas, nuclear, hydro, steam), Wind (on-shore and off-shore turbines and blades), and Electrification (grid-level conversion, solar, storage, and orchestration software).
Recent public filings show that in Q4 2025 the company reported $5.2 billion of consolidated revenue, a 9 % YoY increase driven largely by a 18 % surge in Electrification segment sales. The Wind segment’s order backlog reached $12 billion, supporting an expected 3 GW of new turbine installations in 2026. Across the broader renewable-energy sector, global wind-capacity additions are projected to hit ~500 GW in 2025, underscoring strong demand for the technologies Vernova supplies. However, supply-chain bottlenecks in turbine-blade composites and rising labor costs remain material risks to margin expansion.
For a deeper, data-driven view of GEV’s valuation dynamics, consider exploring the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 4.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.59 > 1.0 |
| NWC/Revenue: -1.99% < 20% (prev 7.06%; Δ -9.05% < -1%) |
| CFO/TA 0.08 > 3% & CFO 4.99b > Net Income 4.88b |
| Net Debt (-8.85b) to EBITDA (3.68b): -2.40 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (276.0m) vs 12m ago -0.72% < -2% |
| Gross Margin: 19.93% > 18% (prev 0.17%; Δ 1975 % > 0.5%) |
| Asset Turnover: 66.51% > 50% (prev 67.85%; Δ -1.34% > 0%) |
| Interest Coverage Ratio: 19.92 > 6 (EBITDA TTM 3.68b / Interest Expense TTM 142.0m) |
Altman Z'' 0.67
| A: -0.01 (Total Current Assets 40.22b - Total Current Liabilities 40.97b) / Total Assets 63.02b |
| B: 0.10 (Retained Earnings 6.15b / Total Assets 63.02b) |
| C: 0.05 (EBIT TTM 2.83b / Avg Total Assets 57.25b) |
| D: 0.09 (Book Value of Equity 4.75b / Total Liabilities 50.72b) |
| Altman-Z'' Score: 0.67 = B |
Beneish M -2.97
| DSRI: 1.04 (Receivables 19.10b/16.80b, Revenue 38.08b/34.93b) |
| GMI: 0.87 (GM 19.93% / 17.41%) |
| AQI: 1.13 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 1.09 (Revenue 38.08b / 34.93b) |
| TATA: -0.00 (NI 4.88b - CFO 4.99b) / TA 63.02b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of GEV shares?
As of February 07, 2026, the stock is trading at USD 779.35 with a total of 3,283,908 shares traded.
Over the past week, the price has changed by +7.29%, over one month by +13.55%, over three months by +41.76% and over the past year by +108.41%.
Over the past week, the price has changed by +7.29%, over one month by +13.55%, over three months by +41.76% and over the past year by +108.41%.
Is GEV a buy, sell or hold?
GE Vernova has received a consensus analysts rating of 4.19.
Therefore, it is recommended to buy GEV.
- StrongBuy: 16
- Buy: 8
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the GEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 819.9 | 5.2% |
| Analysts Target Price | 819.9 | 5.2% |
| ValueRay Target Price | 961.7 | 23.4% |
GEV Fundamental Data Overview February 07, 2026
P/E Trailing = 41.6684
P/E Forward = 53.4759
P/S = 5.2566
P/B = 17.9932
P/EG = 3.0399
Revenue TTM = 38.08b USD
EBIT TTM = 2.83b USD
EBITDA TTM = 3.68b USD
Long Term Debt = 265.0m USD (from longTermDebt, last quarter)
Short Term Debt = 63.0m USD (from shortLongTermDebt, last quarter)
Debt = 328.0m USD (Calculated: Short Term 63.0m + Long Term 265.0m)
Net Debt = -8.85b USD (from netDebt column, last quarter)
Enterprise Value = 191.59b USD (200.11b + Debt 328.0m - CCE 8.85b)
Interest Coverage Ratio = 19.92 (Ebit TTM 2.83b / Interest Expense TTM 142.0m)
EV/FCF = 51.63x (Enterprise Value 191.59b / FCF TTM 3.71b)
FCF Yield = 1.94% (FCF TTM 3.71b / Enterprise Value 191.59b)
FCF Margin = 9.75% (FCF TTM 3.71b / Revenue TTM 38.08b)
Net Margin = 12.83% (Net Income TTM 4.88b / Revenue TTM 38.08b)
Gross Margin = 19.93% ((Revenue TTM 38.08b - Cost of Revenue TTM 30.49b) / Revenue TTM)
Gross Margin QoQ = 21.18% (prev 19.04%)
Tobins Q-Ratio = 3.04 (Enterprise Value 191.59b / Total Assets 63.02b)
Interest Expense / Debt = 13.41% (Interest Expense 44.0m / Debt 328.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.23b (EBIT 2.83b * (1 - 21.00%))
Current Ratio = 0.98 (Total Current Assets 40.22b / Total Current Liabilities 40.97b)
Debt / Equity = 0.03 (Debt 328.0m / totalStockholderEquity, last quarter 11.18b)
Debt / EBITDA = -2.40 (Net Debt -8.85b / EBITDA 3.68b)
Debt / FCF = -2.38 (Net Debt -8.85b / FCF TTM 3.71b)
Total Stockholder Equity = 9.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 4.88b / Total Assets 63.02b)
RoE = 52.36% (Net Income TTM 4.88b / Total Stockholder Equity 9.33b)
RoCE = 29.49% (EBIT 2.83b / Capital Employed (Equity 9.33b + L.T.Debt 265.0m))
RoIC = 23.75% (NOPAT 2.23b / Invested Capital 9.41b)
WACC = 11.92% (E(200.11b)/V(200.43b) * Re(11.92%) + D(328.0m)/V(200.43b) * Rd(13.41%) * (1-Tc(0.21)))
Discount Rate = 11.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.72%
[DCF Debug] Terminal Value 69.60% ; FCFF base≈2.91b ; Y1≈3.59b ; Y5≈6.11b
Fair Price DCF = 244.4 (EV 57.01b - Net Debt -8.85b = Equity 65.86b / Shares 269.5m; r=11.92% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 63.26 | EPS CAGR: 175.6% | SUE: 4.0 | # QB: 1
Revenue Correlation: 66.85 | Revenue CAGR: 18.80% | SUE: 2.52 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.01 | Chg30d=+0.003 | Revisions Net=-6 | Analysts=15
EPS current Year (2026-12-31): EPS=14.61 | Chg30d=+1.365 | Revisions Net=+9 | Growth EPS=-17.4% | Growth Revenue=+16.7%
EPS next Year (2027-12-31): EPS=22.19 | Chg30d=+2.108 | Revisions Net=+8 | Growth EPS=+51.8% | Growth Revenue=+13.4%
P/E Forward = 53.4759
P/S = 5.2566
P/B = 17.9932
P/EG = 3.0399
Revenue TTM = 38.08b USD
EBIT TTM = 2.83b USD
EBITDA TTM = 3.68b USD
Long Term Debt = 265.0m USD (from longTermDebt, last quarter)
Short Term Debt = 63.0m USD (from shortLongTermDebt, last quarter)
Debt = 328.0m USD (Calculated: Short Term 63.0m + Long Term 265.0m)
Net Debt = -8.85b USD (from netDebt column, last quarter)
Enterprise Value = 191.59b USD (200.11b + Debt 328.0m - CCE 8.85b)
Interest Coverage Ratio = 19.92 (Ebit TTM 2.83b / Interest Expense TTM 142.0m)
EV/FCF = 51.63x (Enterprise Value 191.59b / FCF TTM 3.71b)
FCF Yield = 1.94% (FCF TTM 3.71b / Enterprise Value 191.59b)
FCF Margin = 9.75% (FCF TTM 3.71b / Revenue TTM 38.08b)
Net Margin = 12.83% (Net Income TTM 4.88b / Revenue TTM 38.08b)
Gross Margin = 19.93% ((Revenue TTM 38.08b - Cost of Revenue TTM 30.49b) / Revenue TTM)
Gross Margin QoQ = 21.18% (prev 19.04%)
Tobins Q-Ratio = 3.04 (Enterprise Value 191.59b / Total Assets 63.02b)
Interest Expense / Debt = 13.41% (Interest Expense 44.0m / Debt 328.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 2.23b (EBIT 2.83b * (1 - 21.00%))
Current Ratio = 0.98 (Total Current Assets 40.22b / Total Current Liabilities 40.97b)
Debt / Equity = 0.03 (Debt 328.0m / totalStockholderEquity, last quarter 11.18b)
Debt / EBITDA = -2.40 (Net Debt -8.85b / EBITDA 3.68b)
Debt / FCF = -2.38 (Net Debt -8.85b / FCF TTM 3.71b)
Total Stockholder Equity = 9.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.53% (Net Income 4.88b / Total Assets 63.02b)
RoE = 52.36% (Net Income TTM 4.88b / Total Stockholder Equity 9.33b)
RoCE = 29.49% (EBIT 2.83b / Capital Employed (Equity 9.33b + L.T.Debt 265.0m))
RoIC = 23.75% (NOPAT 2.23b / Invested Capital 9.41b)
WACC = 11.92% (E(200.11b)/V(200.43b) * Re(11.92%) + D(328.0m)/V(200.43b) * Rd(13.41%) * (1-Tc(0.21)))
Discount Rate = 11.92% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.72%
[DCF Debug] Terminal Value 69.60% ; FCFF base≈2.91b ; Y1≈3.59b ; Y5≈6.11b
Fair Price DCF = 244.4 (EV 57.01b - Net Debt -8.85b = Equity 65.86b / Shares 269.5m; r=11.92% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 63.26 | EPS CAGR: 175.6% | SUE: 4.0 | # QB: 1
Revenue Correlation: 66.85 | Revenue CAGR: 18.80% | SUE: 2.52 | # QB: 3
EPS next Quarter (2026-03-31): EPS=2.01 | Chg30d=+0.003 | Revisions Net=-6 | Analysts=15
EPS current Year (2026-12-31): EPS=14.61 | Chg30d=+1.365 | Revisions Net=+9 | Growth EPS=-17.4% | Growth Revenue=+16.7%
EPS next Year (2027-12-31): EPS=22.19 | Chg30d=+2.108 | Revisions Net=+8 | Growth EPS=+51.8% | Growth Revenue=+13.4%